We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Evan Dent Evan Dent is a writer focusing on vacuums and floor care. For this ...

The positive frontMIND readout presented at ASCO 2026 puts Incyte on a collision course with Roche in first-line DLBCL. (Angus Liu/Fierce Pharma) Seeking a share of the first-line diffuse large B-cell ...

Learn how to create a beautiful handmade ring step by step with this simple and satisfying jewelry tutorial. Perfect for beginners and DIY jewelry lovers. #JewelryMaking #DIYRing #HandmadeJewelry ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak ...

Antigen-presenting cells activate invariant natural killer T (iNKT) cells, and this combination with α-galactosylceramide subsequently activates the body’s own T cells to fight tumors. This image was ...

Subcutaneous mosunetuzumab with step-up dosing plus six cycles of polatuzumab vedotin enabled fully outpatient delivery without mandatory hospitalization, aligning with access and cost-reduction goals ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. The longtime Tiffany & Co.

Randomization enrolled 1841 systemic-therapy–naïve patients within 12 weeks post-surgery to 1 year pembrolizumab plus daily belzutifan or placebo. Disease-free survival improved despite unreached ...

FARMINGTON HILLS, MICH (WXYZ) — Think Sweet is a vibrant, modern confectionery and café located in Farmington Hills, 32902 Middlebelt Road. Operating under the ...

Both trials are ongoing and will report on overall survival at a subsequent analysis. Findings showed the trial met its primary endpoint demonstrating a statistically significant and clinically ...

Private equity firm Cinven is considering a sale of German software company think-cell, which could be valued at as much as €3 billion ($3.5 billion) in a deal, according to people familiar with the ...